Learn More
Medchemexpress LLC Ethyl (4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-...-12-carboxylate | 892039-23-5 | 99.4% | C29H30N2O5 | 10MG

Supplier: Medchemexpress LLC HY13620810MG
TAN-452 is an orally active, selective peripherally acting δ-opioid receptor (DOR) antagonist derived from naltrindole. It displays high potency at DOR (Ki 0.47 nM; Kb 0.21 nM), shows low brain penetrability, and can attenuate morphine-induced side effects without significantly reducing analgesia. The compound also exhibits antagonist activity at μ- and κ-opioid receptors at higher concentrations.
- Selective peripheral DOR antagonist with subnanomolar potency.
- Low brain penetrability reduces central nervous system exposure.
- Attenuates morphine-induced side effects while preserving analgesia.
- Also antagonizes μ- and κ-opioid receptors at higher concentrations.
- White to off-white solid supplied with high reported purity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.